Health authorities in Hong Kong have excluded a private clinic from coronavirus vaccination operations for vaccinating Germany’s Pfizer-Bioentech. News AFP.
Hong Kong’s health department said on Tuesday that the clinic could no longer be involved in the immunization program because a doctor had breached its immunization program. Authorities say they will recover the unused Snovac vaccine dose from the clinic. A notice from the clinic said, “Get the bioentech vaccine, not the synovac vaccine.”
Four lakh three thousand residents of Hong Kong have taken the first dose of the vaccine. Of these, 2.5 million people have been vaccinated against Sinovac. The rest have been vaccinated by Pfizer-Bioentech.
Not much information has been released about the clinical trials of the Synovac Ticker in China compared to other organizations. Hong Kong has approved Sinovac’s ticker.
Studies conducted in countries other than China show that the effectiveness of Sinovac vaccine is 50 to 60 percent. And the effectiveness of Pfizer-Bioentech vaccine is 94 to 95 percent.
The vaccination program started in Hong Kong last month. According to a recent survey, only 36 percent of adults plan to be vaccinated. However, some epidemiologists in Hong Kong say the Pfizer-Bioentech vaccine is more effective.